Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
Design Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.32.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | SR One Capital Simeon George | 6,526,476 | $61,218,345 | 8.67% | |
| 2. | Point72 Asset Management Steve Cohen | 5,372,004 | $50,389,398 | +61% | 0.06% |
| 3. | Logos Capital Arsani William | 2,500,000 | $23,450,000 | -32% | 1.42% |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,233,099 | $20,946,469 | +31% | 0.12% |
| 5. | Vivo Capital Albert Cha And Frank Kung | 1,612,903 | $15,129,030 | 0.98% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.74 | 17,809 | $66,605.66 | 26,965 | 2024-03-25 | Filing | |
| $3.62 | 9,156 | $33,132.82 | 9,156 | 2024-03-22 | Filing | |
| $3.74 | 1,300 | $4,865.77 | 1,300 | 2024-03-25 | Filing | |
| $2.35 | 21,000 | $49,287.00 | 133,024 | 2023-09-29 | Filing | |
| $20.00 | 700,000 | $14,000,000.00 | 700,000 | 2021-03-30 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.25 | 217,627 | $1,142,541.75 | 1,000,000 | 2025-08-13 | Filing | |
| $5.25 | 345,000 | $1,811,250.00 | 2,655,000 | 2025-08-13 | Filing | |
| $6.27 | 3,806 | $23,863.62 | 20,000 | 2024-12-18 | Filing | |
| $4.25 | 814,874 | $3,463,214.50 | 0 | 2024-08-09 | Filing | |
| $18.63 | 1,455 | $27,105.49 | 4,129,950 | 2022-03-22 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,117,156 | $19,858,924 | 0% | |
| 2. | 1,630,910 | $15,297,936 | 0% | |
| 3. | 771,268 | $7,234,494 | 0% | |
| 4. | 702,306 | $6,587,630 | 0% | |
| 5. | 679,590 | $6,375,975 | 0% |